Latest FDA Stories
Advanced cableless solution detects fetal heart rate and maternal pulse allowing beneficial freedom of movement during labor ANDOVER, Mass., Jan.
First-ever CLIA-waived molecular flu test delivers lab-accurate results at the point of care in less than 15 minutes WALTHAM, Mass., Jan. 7, 2015 /PRNewswire/ -- Alere Inc.
Proposed Clinical Trial Will Assess Potential of FV-100 to Prevent Shingles-Associated PHN Pain EDISON, N.J., Jan. 7, 2015 /PRNewswire/ -- ContraVir Pharmaceuticals, Inc.
Investment to Support Additional FDA Applications, Advance Pipeline of Products & Expand Marketing Efforts Southlake, Texas (PRWEB) January 06, 2015
19 patients who are not eligible for a donor heart transplant will participate in the pivotal clinical study to evaluate the SynCardia Total Artificial Heart for permanent use. TUCSON,
- Bellafill® is the only filler on the market approved in the U.S. for the correction of acne scars SAN DIEGO, Jan.
Lead Immunotherapy Product Candidate GEN-1 to Enter Dose Escalating Clinical Study in the Second Half of 2015 LAWRENCEVILLE, N.J., Jan.
RALEIGH, N.C., Jan. 6, 2015 /PRNewswire/ -- Sprout Pharmaceuticals today announced that Cindy Whitehead has been named CEO, effective immediately.
NiCord® is in clinical development as a treatment for blood cancers including leukemia and lymphoma JERUSALEM, January 6, 2015 /PRNewswire/ -- Gamida Cell [http://www.gamida-cell.com
Treatment of Lennox-Gastaut with External Trigeminal Nerve Stimulation LOS ANGELES, Jan. 6, 2015 /PRNewswire/ -- NeuroSigma®, Inc.